	US 12,454,678 B2
	Muscle differentiation-promoting actions of ergothioneine, ascorbic acid 2-glucoside, ascorbic acid, and combination thereof
Kunio Kosaka, Kobe (JP)
Assigned to NAGASE & CO., LTD., Osaka (JP)
Appl. No. 17/255,779
Filed by NAGASE & CO., LTD., Osaka (JP)
PCT Filed Jun. 11, 2019, PCT No. PCT/JP2019/023114 § 371(c)(1), (2) Date Dec. 23, 2020, PCT Pub. No. WO2020/004014, PCT Pub. Date Jan. 2, 2020.
Claims priority of application No. 2018-124613 (JP), filed on Jun. 29, 2018.
Prior Publication US 2021/0130787 A1, May 6, 2021
Int. Cl. C12N 5/077 (2010.01); A23L 2/52 (2006.01); A23L 33/00 (2016.01); A23L 33/15 (2016.01); A23L 33/175 (2016.01); A61K 31/375 (2006.01); A61K 31/4172 (2006.01); A61K 31/7048 (2006.01)

CPC C12N 5/0658 (2013.01) [A23L 2/52 (2013.01); A23L 33/15 (2016.08); A23L 33/175 (2016.08); A23L 33/40 (2016.08); A61K 31/375 (2013.01); A61K 31/4172 (2013.01); A61K 31/7048 (2013.01); A23V 2002/00 (2013.01); C12N 2500/32 (2013.01); C12N 2500/38 (2013.01)]

15 Claims

1. A method for promoting muscle differentiation of cells, the method comprising:

culturing cells in a low serum culture medium for muscle differentiation comprising ergothioneine.